J&J reportedly eyeing Shockwave Medical for takeover
Cardiovascular device maker Shockwave has a marketed C²⁺ IVL catheter for the treatment of severely calcified coronary artery disease.
Cardiovascular device maker Shockwave has a marketed C²⁺ IVL catheter for the treatment of severely calcified coronary artery disease.
In addition to drug discovery deals, NVIDIA also announced partnerships with J&J MedTech and GE Healthcare for genAI in MedTech.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Microsoft and NVIDIA expand collaboration in healthcare innovation
BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment
Eli Lilly-backed Zephyr AI secures $111m for precision medicine tech
Tierra raises $11.4 in Series A round for predictive AI protein maker